Lim KH - Search Results

1

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.

Lam C, Lim KH, Karumanchi SA. Lam C, et al. Among authors: lim kh. Hypertension. 2005 Nov;46(5):1077-85. doi: 10.1161/01.HYP.0000187899.34379.b0. Epub 2005 Oct 17. Hypertension. 2005. PMID: 16230516 Review.

2

Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?

Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA. Bdolah Y, et al. Among authors: lim kh. Am J Obstet Gynecol. 2008 Apr;198(4):428.e1-6. doi: 10.1016/j.ajog.2007.10.783. Epub 2008 Jan 14. Am J Obstet Gynecol. 2008. PMID: 18191808

3

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Maynard SE, et al. Among authors: lim kh. J Clin Invest. 2003 Mar;111(5):649-58. doi: 10.1172/JCI17189. J Clin Invest. 2003. PMID: 12618519 Free PMC article.

4

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: lim kh. N Engl J Med. 2004 Feb 12;350(7):672-83. doi: 10.1056/NEJMoa031884. Epub 2004 Feb 5. N Engl J Med. 2004. PMID: 14764923 Free article.

5

Uric acid and preeclampsia.

Lam C, Lim KH, Kang DH, Karumanchi SA. Lam C, et al. Among authors: lim kh. Semin Nephrol. 2005 Jan;25(1):56-60. doi: 10.1016/j.semnephrol.2004.09.009. Semin Nephrol. 2005. PMID: 15660336

6

Soluble endoglin contributes to the pathogenesis of preeclampsia.

Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Venkatesha S, et al. Among authors: lim kh. Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4. Nat Med. 2006. PMID: 16751767

7

Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes.

Cohen A, Lim KH, Lee Y, Rana S, Karumanchi SA, Brown F. Cohen A, et al. Among authors: lim kh. Diabetes Care. 2007 Feb;30(2):375-7. doi: 10.2337/dc06-1514. Diabetes Care. 2007. PMID: 17259514 No abstract available.

8

Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.

Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim KH. Salahuddin S, et al. Among authors: lim kh. Am J Obstet Gynecol. 2007 Jul;197(1):28.e1-6. doi: 10.1016/j.ajog.2007.04.010. Am J Obstet Gynecol. 2007. PMID: 17618745 Clinical Trial.

9

The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome.

Young B, Levine RJ, Salahuddin S, Qian C, Lim KH, Karumanchi SA, Rana S. Young B, et al. Among authors: lim kh. J Matern Fetal Neonatal Med. 2010 May;23(5):366-70. doi: 10.1080/14767050903184207. J Matern Fetal Neonatal Med. 2010. PMID: 19701867 Free PMC article.

10

Placental expression of angiogenic factors in Trisomy 13.

Silasi M, Rana S, Powe C, Cohen B, Lim KH, Zsengellér ZK, Karumanchi SA, Stillman IE. Silasi M, et al. Among authors: lim kh. Am J Obstet Gynecol. 2011 Jun;204(6):546.e1-4. doi: 10.1016/j.ajog.2011.02.027. Epub 2011 Apr 20. Am J Obstet Gynecol. 2011. PMID: 21507376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,078 results

Search Page